ANTICOMPLEMENTARY ACTIVITY IN HUMAN SERUM OF LUNG CANCER PATIENTS AND ITS POSSIBLE CLINICAL SIGNIFICANCE
Abstract
Objective: To identify whether the level of anticomplementary activity in serum is different between lung cancer patients and normal subjects.
Method: With a sensitive immune haemolytic assay, the anticomplementary activity in the sera of 50 normal subjects and 61 lung cancer patients were demonstrated.
Results: It was found that all samples contained complement-inhibition activity, although some were of low degree. Increased anticomplementary activity was found to be associated significantly with lung cancer. With the progression of cancer the anticomplementary activity in sera increased in different lung cancer patients.
Conclusion: Such a higher anticomplementary activity in sera of lung cancer patients might be one of the immunosuppressive contents induced by the tumor cells.
Method: With a sensitive immune haemolytic assay, the anticomplementary activity in the sera of 50 normal subjects and 61 lung cancer patients were demonstrated.
Results: It was found that all samples contained complement-inhibition activity, although some were of low degree. Increased anticomplementary activity was found to be associated significantly with lung cancer. With the progression of cancer the anticomplementary activity in sera increased in different lung cancer patients.
Conclusion: Such a higher anticomplementary activity in sera of lung cancer patients might be one of the immunosuppressive contents induced by the tumor cells.